We are live on ! Find out more
NAM

Nexpoint Asset Management Portfolio holdings

AUM $1.49B
1-Year Est. Return 61.08%
This Fund
S&P 500
This Quarter Est. Return
+10.99%
1 Year Est. Return
+61.08%
3 Year Est. Return
+208.69%
5 Year Est. Return
+685.71%
10 Year Est. Return
AUM
$777M
AUM Growth
+$66.8M
Cap. Flow
+$32.8M
Cap. Flow %
4.22%
Top 10 Hldgs %
64.02%
Holding
255
New
33
Increased
12
Reduced
22
Closed
92

Sector Composition

Rank Sector Weight
1 Real Estate 32.94%
2 Financials 15.46%
3 Energy 11.54%
4 Technology 7.45%
5 Industrials 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOMA
101
Loma Negra
LOMA
$1.26B
$435K 0.06%
76,072
SLAC
102
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$417K 0.05%
42,600
SGRY icon
103
Surgery Partners
SGRY
$1.95B
$412K 0.05%
7,486
-1,837
-20% -$90.9K
AYX
104
DELISTED
Alteryx Inc
AYX
$397K 0.05%
5,550
CCL icon
105
CALL
Carnival Corporation Ltd
CCL
$39.4B
$396K 0.05%
19,600
-10,000
-34% -$202K
TOACU
106
DELISTED
Talon 1 Acquisition Corp. Unit
TOACU
$396K 0.05%
38,968
SVFA
107
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$394K 0.05%
40,200
BTMD icon
108
Biote Corp
BTMD
$49.4M
$393K 0.05%
39,736
-9,769
-20% -$96.1K
AEON icon
109
AEON Biopharma
AEON
$13.8M
$389K 0.05%
553
ESBK
110
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$359K 0.05%
15,655
IGAC
111
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
$344K 0.04%
34,900
KKR icon
112
KKR & Co
KKR
$92.8B
$343K 0.04%
5,866
BIOT
113
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$343K 0.04%
34,781
PRTK
114
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$341K 0.04%
114,770
AMYT
115
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$331K 0.04%
40,000
BWAC
116
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$308K 0.04%
30,000
-25,000
-45% -$255K
PSTH
117
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$298K 0.04%
15,000
PMGM
118
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$297K 0.04%
30,000
ROSS
119
DELISTED
Ross Acquisition Corp II
ROSS
$295K 0.04%
30,000
IPOF
120
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$279K 0.04%
27,600
-43,900
-61% -$442K
GCO icon
121
Genesco
GCO
$428M
$267K 0.03%
4,204
EPHY
122
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$257K 0.03%
26,162
AEAE
123
DELISTED
AltEnergy Acquisition Corp
AEAE
$252K 0.03%
+37,500
New +$371K
ARCKU
124
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Units
ARCKU
$252K 0.03%
25,000
GSAQ
125
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$245K 0.03%
24,680

Similar funds

Nexpoint Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Nexpoint Asset Management held 255 positions worth $777M, up 9.4% from $710M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Nexpoint Asset Management deployed $32.8M of net new capital in Q1 2022, opening 33 new positions and adding to 12 existing holdings. Its largest new stake was People's United Financial Inc: 1,991,938 shares worth $39.8M.

By sector, the portfolio is most concentrated in Real Estate at 33% of assets, up from 20% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Vistra, an estimated $12.3M trimmed.

  • Nexpoint Asset Management's largest Q1 2022 buy was People's United Financial Inc: 1,991,938 shares worth $39.8M.
  • Nexpoint Asset Management added most to NexPoint Real Estate Finance in Q1 2022, an estimated $99.5M increase.
  • Nexpoint Asset Management's biggest Q1 2022 reduction was Vistra, cutting an estimated $12.3M.
  • Nexpoint Asset Management fully exited Magellan Health Services, Inc. in Q1 2022, selling an estimated $63M.
  • Nexpoint Asset Management's ten largest holdings make up 64% of its $777M portfolio in Q1 2022.
  • Nexpoint Asset Management opened 33 new positions and closed 92 in Q1 2022.
  • Nexpoint Asset Management's portfolio value rose 9.4% quarter-over-quarter to $777M.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.